Is co-amoxiclav (amoxicillin/clavulanate) safe for patients with Chronic Kidney Disease (CKD) on hemodialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Co-Amoxiclav Safety in Hemodialysis Patients

Co-amoxiclav (amoxicillin/clavulanate) is safe and can be used in CKD patients on hemodialysis, but requires dose adjustment and should be administered after dialysis sessions to prevent drug removal. 1, 2

Key Safety Considerations

Drug Removal During Dialysis

  • Both amoxicillin and clavulanate are removed from circulation by hemodialysis 2
  • Administer co-amoxiclav after the dialysis session to prevent premature drug removal and ensure adequate dosing 1, 3
  • The half-life of amoxicillin during hemodialysis is approximately 2.3 hours 4

Dosing Adjustments Required

  • Standard dose reductions are recommended for patients with impaired kidney function, though the specific regimen should be determined based on infection severity 2, 5
  • For uncomplicated infections, 7 days of therapy is typically sufficient 1
  • For severe or complicated infections, 10-14 days may be required 1
  • High blood levels occur more readily in patients with impaired renal function due to decreased renal clearance of both amoxicillin and clavulanate 2

Beneficial Effects in Dialysis Patients

  • Co-amoxiclav has been shown to restore depressed phagocytic function in polymorphonuclear cells from chronic hemodialysis patients 6
  • This enhancement of immune cell function may be particularly valuable given that hemodialysis patients have impaired phagocyte-dependent host defenses and increased susceptibility to infections 6

Important Clinical Pitfalls to Avoid

Overdosage Risk

  • Renal impairment increases risk of drug accumulation 2
  • Interstitial nephritis resulting in oliguric renal failure has been reported after amoxicillin overdosage 2
  • Crystalluria leading to renal failure can occur with overdosage; maintain adequate fluid intake and diuresis 2
  • Renal impairment from amoxicillin is reversible with drug cessation 2

Drug Interactions

  • Assess for interactions with other medications commonly used in CKD patients 1
  • This is particularly important given the polypharmacy typical in dialysis patients

Monitoring Requirements

  • Monitor for gastrointestinal symptoms (stomach pain, vomiting, diarrhea) which are the most common overdosage manifestations 2
  • Watch for signs of crystalluria or declining renal function 2

Alternative for Penicillin-Allergic Patients

  • For patients with penicillin allergy requiring antibiotic prophylaxis, clindamycin 600 mg orally is recommended 3
  • Clindamycin does not require dose adjustment in CKD and avoids nephrotoxicity concerns 3

Prophylactic Use in Dental Procedures

  • For dental implant surgery or invasive dental procedures in hemodialysis patients not allergic to penicillin, 2 g of amoxicillin orally 1 hour before treatment is recommended 7
  • This prophylaxis is important because hemodialysis patients are immunocompromised and at increased risk for infective endocarditis 7

References

Guideline

Co-Amoxiclav Dosing in Patients with Chronic Kidney Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Amoxicillin Safety in Patients with Chronic Kidney Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.

International journal of clinical pharmacology, therapy, and toxicology, 1982

Research

Impact of co-amoxiclav on polymorphonuclear granulocytes from chronic hemodialysis patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.